PLATYPUS study

Optimising platelet transfusions and medications to prevent bleeding in patients with bone marrow failure syndromes.

An early-stage clinical trial

The PLATYPUS study investigates the best way to prevent bleeding in people with bone marrow failure syndromes that cause low platelet counts, including myelodysplastic syndromes and aplastic anaemia. Using a personalised 15-week “N-of-1” study design, participants will experience three treatment approaches: regular platelet transfusions, tranexamic acid tablets, and current standard care. The trial will evaluate the feasibility, safety, effectiveness, patient experience, and cost implications of each strategy, providing the first clinical evidence on these treatments in this patient population.

The findings of PLATYPUS will guide the design of a larger future trial.

The trial has received funding from a National Blood Authority project grant awarded to Dr Allison Mo.